These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 33168935)

  • 21. KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations.
    Zhang X; Zhang R; Chen H; Wang L; Ren C; Pataer A; Wu S; Meng QH; Ha MJ; Morris J; Xi Y; Wang J; Zhang J; Gibbons DL; Heymach JV; Meric-Bernstam F; Minna J; Swisher SG; Roth JA; Fang B
    Am J Cancer Res; 2020; 10(12):4464-4475. PubMed ID: 33415011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a protein kinase that phosphorylates serine 189 of the mitogen-activated protein kinase homolog ERK3.
    Cheng M; Zhen E; Robinson MJ; Ebert D; Goldsmith E; Cobb MH
    J Biol Chem; 1996 May; 271(20):12057-62. PubMed ID: 8662649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in
    Lee SH; Jeon Y; Kang JH; Jang H; Lee H; Kim SY
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32481524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomal Circ-MEMO1 Promotes the Progression and Aerobic Glycolysis of Non-small Cell Lung Cancer Through Targeting MiR-101-3p/KRAS Axis.
    Ding C; Xi G; Wang G; Cui D; Zhang B; Wang H; Jiang G; Song J; Xu G; Wang J
    Front Genet; 2020; 11():962. PubMed ID: 33005174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
    Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
    Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERK3 associates with MAP2 and is involved in glucose-induced insulin secretion.
    Anhê GF; Torrão AS; Nogueira TC; Caperuto LC; Amaral ME; Medina MC; Azevedo-Martins AK; Carpinelli AR; Carvalho CR; Curi R; Boschero AC; Bordin S
    Mol Cell Endocrinol; 2006 Jun; 251(1-2):33-41. PubMed ID: 16597486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-terminal domain phosphorylation of ERK3 controlled by Cdk1 and Cdc14 regulates its stability in mitosis.
    Tanguay PL; Rodier G; Meloche S
    Biochem J; 2010 Apr; 428(1):103-11. PubMed ID: 20236090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of protein kinase C beta activates ERK3.
    Sauma S; Friedman E
    J Biol Chem; 1996 May; 271(19):11422-6. PubMed ID: 8626698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4.
    Aberg E; Perander M; Johansen B; Julien C; Meloche S; Keyse SM; Seternes OM
    J Biol Chem; 2006 Nov; 281(46):35499-510. PubMed ID: 16971392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity.
    Mathien S; Déléris P; Soulez M; Voisin L; Meloche S
    Mol Cell Biol; 2017 May; 37(9):. PubMed ID: 28167606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells.
    Elkhadragy L; Chen M; Miller K; Yang MH; Long W
    Mol Oncol; 2017 Feb; 11(2):194-207. PubMed ID: 28079973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
    Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
    J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of ERK1/2 and ERK3 during normal rat fetal lung development.
    Kling DE; Brandon KL; Sollinger CA; Cavicchio AJ; Ge Q; Kinane TB; Donahoe PK; Schnitzer JJ
    Anat Embryol (Berl); 2006 Mar; 211(2):139-53. PubMed ID: 16374608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cloning, isolation and characterisation of ERK3 gene from chewing-tobacco induced oral squamous cell carcinoma.
    Rai R; Mahale A; Saranath D
    Oral Oncol; 2004 Aug; 40(7):705-12. PubMed ID: 15172640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.
    Elkhadragy L; Alsaran H; Morel M; Long W
    J Biol Chem; 2018 Oct; 293(42):16193-16205. PubMed ID: 30166347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined use of PI3K and MEK inhibitors synergistically inhibits lung cancer with EGFR and KRAS mutations.
    Jiang ZB; Huang J; Xie C; Li X; Liu L; He J; Pan H; Huang L; Fan XX; Yao XJ; Xie Y; Li N; Liu L; He JX; Leung EL
    Oncol Rep; 2016 Jul; 36(1):365-75. PubMed ID: 27121230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-138 inhibits proliferation and induces apoptosis of laryngeal carcinoma via targeting MAPK6.
    Zhou YH; Huang YY; Ma M
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5569-5575. PubMed ID: 30229830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteasome- and p38-dependent regulation of ERK3 expression.
    Zimmermann J; Lamerant N; Grossenbacher R; Furst P
    J Biol Chem; 2001 Apr; 276(14):10759-66. PubMed ID: 11148204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary structure, expression and chromosomal locus of a human homolog of rat ERK3.
    Meloche S; Beatty BG; Pellerin J
    Oncogene; 1996 Oct; 13(7):1575-9. PubMed ID: 8875998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The status of KRAS mutations in patients with non-small cell lung cancers from mainland China.
    Li M; Liu L; Liu Z; Yue S; Zhou L; Zhang Q; Cheng S; Li RW; Smith PN; Lu S
    Oncol Rep; 2009 Nov; 22(5):1013-20. PubMed ID: 19787214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.